J Biol Chem, Vol. 274, Issue 36, 25227-25236, September 3, 1999
Interaction of Nucleotides with Asp351 and the
Conserved Phosphorylation Loop of Sarcoplasmic Reticulum
Ca2+-ATPase*
David B.
McIntosh
and
David G.
Woolley
From the Department of Chemical Pathology, University of Cape Town
Medical School, 7925 Cape Town, South Africa
David H.
MacLennan
From the Banting and Best Department of Medical Research, C. H. Best Institute, University of Toronto,
Toronto, Ontario M5G 1L6, Canada
Bente
Vilsen, and
Jens Peter
Andersen§
From the Department of Physiology, University of Aarhus,
DK-8000 Aarhus C, Denmark
 |
ABSTRACT |
The nucleotide binding properties of mutants with
alterations to Asp351 and four of the other residues
in the conserved phosphorylation loop,
351DKTGTLT357, of sarcoplasmic reticulum
Ca2+-ATPase were investigated using an assay based on the
2',3'-O-(2,4,6-trinitrophenyl)-8-azidoadenosine triphosphate (TNP-8N3-ATP) photolabeling of
Lys492 and competition with ATP. In selected cases where
the competition assay showed extremely high affinity, ATP binding was
also measured by a direct filtration assay. At pH 8.5 in the absence of
Ca2+, mutations removing the negative charge of
Asp351 (D351N, D351A, and D351T) produced pumps that bound
MgTNP-8N3-ATP and MgATP with affinities 20-156-fold higher
than wild type (KD as low as 0.006 µM), whereas the affinity of mutant D351E was comparable
with wild type. Mutations K352R, K352Q, T355A, and T357A lowered the
affinity for MgATP and MgTNP-8N3-ATP 2-1000- and
1-6-fold, respectively, and mutation L356T completely prevented photolabeling of Lys492. In the absence of
Ca2+, mutants D351N and D351A exhibited the highest
nucleotide affinities in the presence of Mg2+ and at
alkaline pH (E1 state). The affinity of mutant D351A for MgATP was
extraordinarily high in the presence of Ca2+
(KD = 0.001 µM), suggesting a
transition state like configuration at the active site under these
conditions. The mutants with reduced ATP affinity, as well as mutants
D351N and D351A, exhibited reduced or zero CrATP-induced
Ca2+ occlusion due to defective CrATP binding.
 |
INTRODUCTION |
The Ca2+-ATPase of sarcoplasmic reticulum is a
10-transmembrane helix Ca2+/H+ pump that
hydrolyzes ATP through transient formation of an aspartyl phosphorylated intermediate (1-4). The phosphorylated aspartate residue (Asp351) and the binding site for MgATP are located
in the large cytoplasmic domain of the pump protein, whereas the
Ca2+ transport sites are in the membrane domain (5). It is
a well documented property of the pump that binding of Ca2+
at the transport sites is required to activate phosphoryl transfer from
ATP to Asp351. However, the long range intramolecular
interaction between the Ca2+ sites and the nucleotide
binding site that triggers formation of a transition state for
phosphoryl transfer and the nature of this transition state are not
well understood. Electrostatic interactions in the vicinity of the
phosphoryl groups of ATP and Asp351 and other catalytic
residues may be expected to dominate during ATP binding and in the
transition state and possibly drive changes in the transport sites (6).
The unphosphorylated Ca2+-ATPase exists in a
Ca2+- and pH-dependent equilibrium (7) of
several (E1/E2) conformational states (Scheme 1) that appear to
interact differently with ATP.
|
|
|
|
Although in the presence of Mg2+ all of the states
indicated in Scheme 1 exhibit rather high affinities for ATP
(KD in the range 0.5-20 µM) (8, 9),
only the E1Ca2 state is primed for transfer of the
-phosphoryl group to Asp351. As counterions to
Ca2+ (3), protons bind to the transport sites in place of
Ca2+, stabilizing the E2 conformation. The fully protonated
E2 form (E2H3 in Scheme 1) is phosphorylated by
Pi at Asp351 when the pump works in the reverse
mode but cannot be phosphorylated by ATP. Since ATP accelerates
Pi binding (10) and dephosphorylation (11), modulates
Pi
HOH exchange (12), and binds fairly tightly to the
vanadate complexed E2 form (13), E2H3 must be able to bind
ATP without preventing the access of Pi to
Asp351, suggesting that the
-phosphoryl group of the
bound ATP is at some distance from Asp351 in this
conformation, in contrast to the E1Ca2 state. A change in
the interaction of bound nucleotide with Asp351 related to
enzyme activation by Ca2+ is clearly demonstrated with
TNP-8N3-ATP1 that
has been covalently attached to Lys492 by light activation
(14-16). Tethering the nucleotide still permits Ca2+-dependent hydrolysis in the forward
direction of catalysis, proving direct interaction with
Asp351, and yet has little effect on
Pi-dependent phosphorylation in the absence of
Ca2+, showing that the nucleotide, or at least a portion of
it, shifts position with respect to the aspartyl residue upon
Ca2+ binding.
The phosphorylated aspartate and adjoining residues on the
COOH-terminal side, segment 351DKTGTLT357,
termed the phosphorylation loop in this study, are highly conserved in
P-type ATPases (17), and previous mutational analysis has documented
their functional importance (18, 19). Besides Asp351, also
Lys352, Thr355, Leu356, and
Thr357 are critical to Ca2+ transport as well
as phosphorylation (19), and further clarification of the distinct
roles of these residues in nucleotide binding, phosphoryl transfer, and
long range interaction with the Ca2+ sites may aid
understanding of energy transduction in the pump. In this study, we
assess the effects on nucleotide binding of mutations to the
phosphorylation loop residues that previously were shown to result in
severely impaired or inactive pumps (18, 19). ATP binding is measured
mainly through inhibition of TNP-8N3-ATP photolabeling of
Lys492, which has recently been successfully applied to
Ca2+-ATPase mutated in segment
487FSRDRK492 (16). In selected cases where the
affinity is extremely high, binding is also measured by a direct
filtration assay. In addition, the effects of the mutations on
Ca2+ occlusion induced with CrATP are determined. The
results show that most of the mutations in the phosphorylation loop
affect nucleotide binding and disrupt CrATP-induced Ca2+
occlusion. Our analysis of mutations to Asp351 reveals high
intrinsic nucleotide binding energies when the negative charge is
removed, particularly in the presence of Mg2+ and
Ca2+, i.e. in the E1Ca2 state
(KD = 0.001 µM for mutant D351A). These favorable interactions may be utilized to gain the transition state and to provoke conformational changes that communicate with the
transport sites.
 |
EXPERIMENTAL PROCEDURES |
The mutant Ca2+-ATPase cDNAs used in this study
were the same as those described previously (18, 19) but were shuttled
to vector pMT2 (20) to obtain higher expression levels in COS-1 cells
(18, 21). COS-1 cell microsomes containing expressed wild-type or
mutated Ca2+-ATPase were isolated by differential
centrifugation 48-72 h after transfection (18). The exogenous
Ca2+-ATPase content of the microsomal fraction was assayed
with a specific sandwich enzyme-linked immunosorbent assay (21).
The synthesis of [
-32P]TNP-8N3-ATP,
photolabeling of COS-1 cell microsomes, the inhibition by ATP,
quantification of labeled bands by electronic autoradiography
("imaging") following SDS-polyacrylamide gel electrophoresis, curve
fitting equations and calculations of the "true"
KD(ATP) have been described previously (16, 22). For fitting of the TNP-8N3-ATP labeling data, the Hill equation with or without a linear component was used, and the Hill
coefficient was set to 1. The concentration of free Ca2+
was set with 5 mM EGTA and variable amounts of total
CaCl2 as calculated according to Fabiato and Fabiato (23)
taking the Mg2+ concentration and pH into consideration.
CrATP-dependent Ca2+ occlusion was measured as
before (16, 24).
Equilibrium ATP binding to mutants D351N and D351A was also measured by
filtration. COS-1 cell microsomes (1 µl of stock microsomes in 1 ml;
approximately 0.5 pmol of Ca2+-ATPase protein/ml) were
incubated with [
-32P]ATP, 1 mM
[3H]sucrose, and other components as indicated in the
Fig. 7 legend for 1 min at 25 °C, and the sample was filtered on
Millipore GS 0.22-µm filters under mild vacuum. The radioactivity of
the filter was measured by liquid scintillation counting. The wet
volume of the filter was determined from the tritium radioactivity
(range: 28-42 µl), allowing determination of the radioactivity of
unbound nucleotide, which was subtracted from the total 32P
cpm to obtain the amount of ATP bound to the microsomes.
The formation of a slowly dissociating CrATP complex with the
Ca2+-ATPase in the presence of Ca2+ was
followed through the inhibition of
[
-32P]TNP-8N3-ATP photolabeling.
Microsomes containing expressed wild-type or mutated
Ca2+-ATPase were incubated at 37 °C with CrATP for up to
1 h. Aliquots were taken at timed intervals and diluted 50-fold
into irradiation medium with 0.5 µM
[
-32P]TNP-8N3-ATP. The samples were
irradiated for 1 min and subjected to SDS-polyacrylamide gel
electrophoresis, and the radioactivity was quantified by electronic
autoradiography as described previously (16).
 |
RESULTS |
Twenty-four mutations have previously been introduced into the
conserved phosphorylation loop of the Ca2+-ATPase between
Ile348 and Thr357 (18, 19). All the mutants
with alteration to the aspartic acid residue Asp351
receiving the phosphoryl group during catalysis are inactive, and so
are the mutants with alterations to Lys352, even in the
case of the most conservative replacement of Lys352 with
arginine. Activity is not affected by conservative replacements of
Thr355 or Thr357 with serine, but replacement
with alanine reduces the Ca2+ transport activity as well as
the level of phosphoenzyme. Replacement of Leu356 with
isoleucine is without effect on activity, but mutation to threonine
inactivates the pump. Hence, these residues (nine mutants in all; see
Table I) were selected for the present
study of nucleotide binding properties.
View this table:
[in this window]
[in a new window]
|
Table I
Nucleotide binding parameters and CrATP-dependent
Ca2+ occlusion of wild-type Ca2+-ATPase and
mutants
For nucleotide binding, medium was 25 mM HEPPS/TMAH, pH
8.5, 20% (w/v) glycerol, 1 mM MgCl2, 0.5 mM EGTA. For CrATP-dependent Ca2+
occlusion, medium was 50 mM TES/Tris, pH 7.0, 100 mM NaCl, 5 mM MgCl2, 40 µM 45CaCl2, and 1 mM CrATP.
|
|
The assay for nucleotide binding, which is based on specific
[
-32P]TNP-8N3-ATP photolabeling of
Lys492 and nucleotide competition, has been validated
previously (16). Results obtained under optimum labeling conditions at
pH 8.5 demonstrated that this assay is able to produce highly accurate
values for TNP-8N3-ATP and ATP binding affinities of
Ca2+-ATPase expressed in COS-1 cell microsomes (16). In
assessing the results to be described below, it is furthermore useful
to know that TNP-8N3-ATP is a substrate of the
Ca2+-ATPase, albeit a slow one, whether untethered or
tethered to Lys492 by photolabeling (15, 16). This means
that the position of the
-phosphoryl group of the bound nucleotide
must be similar, although probably not identical, to that of bound ATP.
The concentration dependence of TNP-8N3-ATP photolabeling
of wild-type and mutant Ca2+-ATPases at pH 8.5 in the
presence of Mg2+ and absence of Ca2+ (presence
of EGTA) is shown in Fig. 1A.
The data could be fitted satisfactorily to the sum of a simple
hyperbolic binding function and a linear component, the latter
representing nonspecific labeling as previously explained (16). For
most of the mutants, the linear component was small and insignificant,
but as seen in Fig. 1 the linear component was rather prominent for
mutant K352Q, for unknown reasons. The derived
K0.5 values corresponding to the hyperbolic component are listed in Table I. It can been seen that removal of the
negative charge on Asp351, as shown by mutants D351N,
D351A, and D351T, led to a pronounced increase in
TNP-8N3-ATP affinity, with D351N exhibiting the largest increase of 156-fold. By contrast, mutation D351E, which conserves the
negative charge, did not significantly affect the
TNP-8N3-ATP binding affinity. The concentration of
Ca2+-ATPase in the irradiation assay was approximately 0.4 nM for the tightly binding mutants and approximately 2 nM for the rest to ensure a reasonably high ratio of free
to bound nucleotide, thereby allowing the total concentration to be
equated with the free concentration.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 1.
TNP-8N3-ATP photolabeling
(A) and ATP inhibition (B).
A, photolabeling was performed in 25 mM
HEPPS/TMAH, pH 8.5, 1 mM MgCl2, 0.5 mM EGTA, 20% (w/v) glycerol, the indicated concentrations
of [ -32P]TNP-8N3-ATP, and a 125-625-fold
dilution of stock COS-1 cell microsomes (to 0.4-2 nM
Ca2+-ATPase). The samples were subjected to
SDS-polyacrylamide gel electrophoresis, and the relevant radioactive
bands were quantified by imaging. The data were fitted to the sum of a
hyperbolic function and a linear function, the latter representing
nonspecific labeling, and the derived K0.5
values for the hyperbolic function are shown in Table I. B,
experiments were performed as above at a concentration of
TNP-8N3-ATP of 3 × K0.5 for
each mutant Ca2+-ATPase (see Table I), except for T357A and
K352Q, where it was equal to the K0.5, and ATP
was included at the concentrations shown. In two cases, namely
mutations K352Q and T357A, additional Mg2+ was included at
1 and 3 mM ATP to a total concentration of 2 and 4 mM, respectively. The data were fitted to a simple binding
function with an offset representing nonspecific labeling. The
KD(ATP) values calculated from the
derived K0.5 values as described (16) are listed
in Table I. , wild type; , D351N; , D351T; , D351A; ,
D351E; , K352R; , K352Q; , T355A; , T357A.
|
|
Mutation K352Q, which removes the positive charge of
Lys352, lowered the affinity for TNP-8N3-ATP at
least 5-fold, whereas the more conservative replacement with arginine,
K352R, was without significant effect. Mutation T355A was likewise
silent, but T357A lowered the affinity for the TNP nucleotide about
6-fold. Mutant L356T exhibited a low level of labeling that was linear
with increasing concentrations of TNP-8N3-ATP up to 30 µM. This indicates that either Lys492 was not
being labeled or the affinity was extremely poor
(K0.5 estimated to be >50
µM).
The inhibition of photolabeling by ATP under the same buffer conditions
is shown in Fig. 1B, and the derived true
KD values assuming competitive inhibition are listed
in Table I. Usually, the concentration of TNP-8N3-ATP was
fixed at 3 × K0.5 to ensure that the
binding site is close to saturation; however, in the case of mutants
K352Q and T357A, inhibition was so poor at these concentrations that
the TNP-8N3-ATP concentrations were lowered to the
K0.5 in each case. It is apparent that removal of the negative charge on Asp351 caused a large increase in
affinity for ATP (83-fold, 45-fold, and 22-fold for D351N, D351T, and
D351A, respectively) similar to that seen for TNP-8N3-ATP.
Mutations D351E and T355A appeared to slightly decrease the affinity
for ATP (1.5-2-fold compared with wild type). While mutation K352R
resulted in a 13-fold reduction of ATP affinity, K352Q led to a
spectacular effect, reducing the ATP affinity close to 1000-fold.
Mutation T357A decreased the affinity for ATP at least 40-fold. Because
the affinity of the latter two mutants was too low for complete
inhibition to be reached, the choice of the offset of the binding curve
was somewhat uncertain in these cases, resulting in corresponding
uncertainties with respect to the exact
KD(ATP) values.
Hence, the results shown in Fig. 1 indicate that the most disruptive
mutation in terms of nucleotide binding is L356T, followed by K352Q,
T357A, and K352R. The latter three mutations affected ATP binding much
more than the binding of TNP-nucleotide, similar to the situation with
mutations close to Lys492 (16). All of the mutants in which
the negative charge on Asp351 was removed exhibited a large
increase in affinity for both nucleotides, with D351N being the most
dramatic. On the other hand, mutation D351E had little effect on the
binding of either nucleotide.
Nucleotide binding and the coupling between the catalytic and transport
sites can be assessed by measuring CrATP-induced Ca2+
occlusion. CrATP slowly forms a complex with the
Ca2+-ATPase at the catalytic site without phosphorylating
Asp351 and causes simultaneous occlusion of
Ca2+ at the transport sites (24-27). Because this complex
is very stable, requiring hours to dissociate,
45Ca2+ occlusion with CrATP can be measured in
Ca2+-ATPase expressed in COS-1 cell microsomes by size
exclusion HPLC following detergent solubilization of the microsomes
(24). The results of such measurements on the wild type and selected
mutants are shown in Fig. 2 and
summarized in Table I. The microsomes were incubated 1 h at
37 °C with 1 mM CrATP and 40 µM
45Ca2+, i.e. just about enough to
ensure saturation of the occlusion reaction in the wild-type enzyme,
before solubilization and chromatography. Equal amounts of expressed
Ca2+-ATPase, according to enzyme-linked immunosorbent assay
measurements, were chromatographed, so the elution profiles are
comparable. The control represents microsomes without expressed
Ca2+-ATPase, i.e. harvested from COS-1 cells
mock-transfected with the expression vector without insert. The amount
of control microsomes in mg of total membrane protein corresponds to
that chromatographed in the case of the wild type. The distinct peak of
radioactivity eluting between 14 and 15 min in the experiment with the
wild type and in some of the experiments with mutants represents
Ca2+ occluded in the detergent-solubilized monomeric enzyme
(24). As can be seen, there was no such peak for mutants D351N and
D351A, and hence these mutants did not occlude Ca2+.
Mutants K352R and T355A showed partial occlusion, and mutants K352Q,
L356T, and T357A also failed to occlude Ca2+.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
CrATP-dependent Ca2+
occlusion. Occlusion of Ca2+ by wild-type or mutant
Ca2+-ATPase expressed in COS-1 cell microsomes was measured
following incubation for 1 h at 37 °C in 50 mM
TES/Tris, pH 7.0, 100 mM NaCl, 5 mM
MgCl2, 40 µM 45CaCl2,
and 1 mM CrATP. The graphs show the size
exclusion HPLC elution profiles of 45Ca associated with
solubilized protein originating from microsomes harvested from cells
transfected with wild-type or mutant Ca2+-ATPase cDNA
and from control microsomes from cells transfected with the expression
vector without insert. The difference between the test and control
curves corresponding to the elution time of the monomeric
Ca2+-ATPase at 14-15 min provides a measure of the
occluded Ca2+. Equivalent amounts of wild-type and mutant
Ca2+-ATPase protein (as determined by enzyme-linked
immunosorbent assay) were applied to the column in the experiments
shown. A summary of the results is shown in Table I.
|
|
Thus, for some mutations, notably those that slightly or grossly lower
the affinity for ATP, the effect on CrATP-induced Ca2+
occlusion seems to be correlated with the change in ATP binding affinity. However, mutations to Asp351, which caused a huge
increase in affinity for ATP, also appeared to prevent CrATP-induced
Ca2+ occlusion. In order to elucidate whether this was due
to defective CrATP complexation at the catalytic site or an uncoupling
of CrATP complexation and Ca2+ occlusion, we devised an
assay wherein the microsomes were incubated with CrATP for up to 1 h at 37 °C and then diluted substantially prior to photolabeling
with TNP-8N3-ATP. The affinity of the
Ca2+-ATPase for CrATP is not high, and a concentration of
CrATP in the millimolar range is required to obtain saturation so that occlusion occurs in a reasonable period of time. To minimize the competitive binding of contaminant ATP that might be present in the
CrATP preparation, the samples were irradiated under conditions where
the affinity for TNP-8N3-ATP is reasonably high and that for ATP is fairly low (pH 8.5 in the presence of EDTA). Also with this
in mind, a concentration of TNP-8N3-ATP of approximately 10× K0.5 was chosen. As seen in Fig.
3, photolabeling of the wild-type Ca2+-ATPase was inhibited by CrATP in a
time-dependent manner, indicative of a gradual and
effectively irreversible complexation of CrATP at the catalytic site.
In mutants D351N and D351A, CrATP failed to inhibit photolabeling,
showing that the irreversible binding of CrATP had not occurred. This
explains the lack of CrATP-induced Ca2+ occlusion in these
mutants.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
CrATP inhibition of TNP-8N3-ATP
photolabeling. The microsomes were incubated at 37 °C in 50 mM MOPS/TMAH, pH 7.0, 100 mM NaCl, 2 mM MgCl2, 0.1 mM CaCl2,
and without (open symbols) or with
(solid symbols) 1 mM CrATP. At the
indicated times, aliquots were diluted 50-fold into irradiation medium
containing 25 mM HEPPS/TMAH, pH 8.5, 2 mM EDTA,
20% (w/v) glycerol, and 0.5 µM
[ -32P]TNP-8N3-ATP. The samples were
irradiated and subjected to SDS-polyacrylamide gel electrophoresis, and
the radioactivity was quantified. Circles, wild type;
squares, D351N; triangles, D351A.
|
|
The buffer conditions in the above binding experiments with
TNP-8N3-ATP and ATP (pH 8.5, in the presence of
Mg2+ and absence of Ca2+) largely favor
accumulation of the E1 state of the wild-type Ca2+-ATPase,
whereas the E2H and E2H3 forms (cf. Scheme 1)
would predominate at neutral and acid pH in the absence of
Ca2+ (7). To better understand the huge increase in
nucleotide affinity induced by mutations D351N and D351A and the
implications for the catalytic mechanism, we investigated the influence
of pH, Mg2+, and Ca2+, as well as thapsigargin,
a tightly binding inhibitor that appears to lock the enzyme into E2 or
an "E2-like" state (28). Results of these studies are presented in
Figs.
4-6
and summarized in Table II in terms of
derived dissociation constants.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Photolabeling (A) and
inhibition by ATP (B) of wild-type
Ca2+-ATPase at pH 7.0. Photolabeling was performed as
in Fig. 1 except that the buffer was MOPS, pH 7.0. Additional
MgCl2 was added at high ATP concentrations as in Fig. 1.
The dashed line in A shows the curve
obtained after subtraction of the linear component. The
insets show portions of the autoradiographs of the
SDS-polyacrylamide gels at the level of the expressed wild-type
Ca2+-ATPase. In A, there are 10 lanes with
concentrations of TNP-8N3-ATP as follows: 0.03, 0.1, 0.3, 0.6, 1, 3, 6, 10, 20, and 30 µM; in B, there are also 10 lanes with concentrations of ATP of 0, 0.3, 1, 3, 10, 30, 100, 300, 1000, and 3000 µM.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of Mg2+ and
Ca2+ on TNP-8N3-ATP photolabeling (A and B) and ATP inhibition (C and D) of mutant D351N at pH 7.0 (A and C) and pH 8.5 (B and
D). Photolabeling was performed as in Figs. 1 and
4, in the presence of 1 mM MgCl2 + 0.5 mM EGTA ( ), 2 mM EDTA ( ), or 1 mM MgCl2 plus 0.05 mM
CaCl2 ( ).
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of Mg2+ and
Ca2+ on TNP-8N3-ATP photolabeling (A and B) and ATP inhibition (C and D) of mutant D351A at pH 7.0 (A and C) and pH 8.5 (B and
D). Photolabeling was performed as in Figs. 1 and
4, in the presence of 1 mM MgCl2 plus 0.5 mM EGTA ( ), 2 mM EDTA ( ), or 1 mM MgCl2 plus 0.05 mM
CaCl2 ( ).
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Effect of Mg2+, Ca2+, pH, and thapsigargin on
nucleotide binding parameters of wild-type Ca2+-ATPase and
mutants D351N and D351A
|
|
As previously noted (16), the efficiency of the specific incorporation
of TNP-8N3-ATP photolabel into the Ca2+-ATPase
expressed in COS-1 cell membrane is almost as high at neutral pH
compared with alkaline pH, contrary to the situation for
Ca2+-ATPase in sarcoplasmic reticulum. This made it
feasible to extend the photolabeling assay to pH 7.0 for the expressed
wild-type and mutant Ca2+-ATPases. The
TNP-8N3-ATP concentration dependence of photolabeling of
the wild-type Ca2+-ATPase at pH 7.0 in the presence of
Mg2+ is shown in Fig. 4A. The concentration
dependence is characterized by hyperbolic and linear phases, with the
specific hyperbolic component dominating in the low concentration
range. This is similar to the results obtained at pH 8.5 (see Ref. 16
for a detailed description of the wild-type data at pH 8.5). The
inset shows autoradiographs of the same experiments, and it
can be seen that even at pH 7.0 the ratio of Ca2+-ATPase
labeling to background labeling is reasonably high. The inhibition by
ATP of the photolabeling of the wild type at pH 7.0 in the presence of
a concentration of TNP-8N3-ATP of 3 × K0.5 is shown in Fig. 4B. Similar
experiments at pH 7.0 were performed in the absence of Mg2+
(in the presence of 2 mM EDTA), the amount of extra
labeling in the 10-30 µM range being much less in this
condition (data not shown). In addition, experiments in the absence of
Mg2+ were carried out at pH 8.5 for comparison. As seen in
Table II, the decrease in pH from 8.5 to 7.0 enhanced the affinity of
the wild-type Ca2+-ATPase for TNP-8N3-ATP
2-fold in the presence of Mg2+, whereas the affinity for
ATP was reduced 16-fold under these conditions. The effects of
Mg2+ were also quite different for the two nucleotides, the
divalent cation strongly enhancing ATP binding (33-fold at pH 8.5 and
9-fold at pH 7.0) but diminishing the affinity for
TNP-8N3-ATP, especially at pH 8.5. A trend to higher
affinity for ATP in the presence of Mg2+ and at alkaline pH
has previously been reported for the Ca2+-ATPase in the
native sarcoplasmic reticulum membrane (9, 29, 30), although the
effects appear to be somewhat larger in the present study, possibly
because of the presence of glycerol (31), which is added as a nitrene scavenger.
As seen in Figs. 5 and 6 and Table II, the observation of higher
nucleotide affinities of mutants D351N and D351A relative to wild type
could be confirmed at pH 7.0 as well as in the absence of
Mg2+, although the pH and Mg2+ influenced to
some extent the magnitude of the affinity increase induced by the
mutations. At pH 8.5, the mutations seem to negate the anomalous
inhibitory effect of Mg2+ on TNP-8N3-ATP
binding to wild-type Ca2+-ATPase, the divalent cation
actually enhancing the affinity 2-3-fold in the case of D351N and
having no significant effect for mutation D351A. The
Mg2+-induced enhancement of ATP affinity was even more
pronounced in mutant D351N (200-fold) than in the wild type at pH 8.5 but was much less (only 2-fold) at pH 7.0.
It was previously demonstrated that thapsigargin is without effect on
TNP-8N3-ATP photolabeling of the wild-type
Ca2+-ATPase but lowers the affinity for ATP more than
100-fold (16). In the presence of thapsigargin, both of the mutants
D351N and D351A displayed much lower affinity for either nucleotide
than in the absence of the inhibitor (Table II), but the effect of the
inhibitor was most pronounced for ATP (more than 700-fold decrease in
ATP affinity of both mutants). Importantly, even in the
thapsigargin-bound state, the mutations induced a significant increase
in affinity for both nucleotides. Since thapsigargin is believed to
stabilize E2 or an "E2-like state" (28), this finding clearly
demonstrates that the affinity increase resulting from removal of the
negative charge of Asp351 is not an exclusive property of
E1 forms. On the other hand, it is noteworthy that the magnitudes of
the effects induced by the mutations were somewhat smaller in the
presence of thapsigargin than in its absence (cf. also Table
III and below).
Because Ca2+ binding to the transport sites on the
wild-type Ca2+-ATPase activates rapid transfer of the
-phosphoryl group of bound ATP to the enzyme, the affinity of the
wild-type enzyme for ATP in the presence of Ca2+ cannot be
determined under equilibrium conditions, but a value of 3 µM for the KD(ATP) of the
wild-type enzyme in the presence of Ca2+ has been estimated
on the basis of rapid kinetic measurements of association and
dissociation rate constants (8). The inability of mutants D351N and
D351A to phosphorylate offered a unique possibility for studies of the
effect of Ca2+ on equilibrium ATP binding to these mutants.
As seen in Figs. 5 and 6 and Table II, we determined the affinities for
TNP-8N3-ATP as well as ATP in the presence of
Mg2+ and Ca2+ at both pH 8.5 and pH 7.0. For
mutant D351N, Ca2+ binding caused a significant 4-fold
reduction of the affinity for ATP at pH 8.5, whereas, surprisingly, at
pH 7.0 the affinities for both nucleotides were increased (10-fold for
TNP-8N3-ATP and 20-fold for ATP). For mutant D351A,
Ca2+ binding caused a tremendous increase in ATP affinity,
resulting in a KD of about 0.001 µM at
both pH values (300-fold increase in affinity at pH 7.0 and 23-fold at
pH 8.5). Also, the affinity for the TNP-nucleotide increased very much
in the presence of Ca2+ in this mutant (10-fold at pH 8.5 and 40-fold at pH 7.0).
The important implications of these
Ca2+-dependent changes in ATP binding and the
extremely high affinities for ATP prompted us to try to verify the
photolabeling results by measuring ATP binding directly by filtration.
This method is not generally applicable to expressed wild-type or
mutant proteins, since each data point requires several µg of protein
when the KD is in the micromolar range or above, and
also there could be a problem with the specificity under these
conditions considering the large number of proteins in the COS cell
microsomes. Fig. 7 shows the results obtained at pH 7.0, and as can be seen extremely tight
[
-32P]ATP binding to mutants D351A and D351N could
indeed be measured in the presence of Ca2+. The
KD values (0.0012 and 0.030 µM,
respectively) are the same or very similar to those found by
photolabeling (0.0014 and 0.028 µM, respectively). The
binding in the absence of Ca2+ was much weaker, and the
data points are compatible with the KD values
obtained by photolabeling (0.42 and 0.57 µM, respectively, Table II). It could be noted that the filtration experiments were performed in the absence of glycerol, and the similarity of the photolabeling and filtration measurements indicates that the cosolvent is not affecting the KD values
significantly under these conditions. Using the filtration assay, we
also obtained a few data points at pH 8.5, confirming that the addition
of Ca2+ increases the ATP affinity of mutant D351A and
decreases the ATP affinity of mutant D351N (results not shown).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 7.
ATP binding to mutants D351N
(closed symbols) and D351A (open symbols) determined by filtration. Binding of
[ -32P]ATP was measured with 0.5-0.6 pmol of
Ca2+-ATPase in 50 mM MOPS/TMAH, pH 7.0, 1 mM MgCl2, 1 mM
[3H]sucrose, either 0.1 mM CaCl2
(circles) or 1 mM EGTA (triangles),
and variable concentrations of [ -32P]ATP as indicated.
The duplicate data points at each concentration of ATP were from
separate experiments performed on different days. The data points in
the presence of Ca2+ were fitted to the Hill equation with
the Hill coefficient set to 1 and yielded KD values
of 0.030 and 0.0012 µM for mutants D351N and D351A,
respectively. Similar KD values were obtained on two
different preparations of mutants D351N and D351A.
|
|
The increase in the affinity for TNP-8N3-ATP upon
Ca2+ binding to the transport sites of mutants D351N and
D351A at pH 7.0 (10- and 40-fold, respectively) permitted investigation
of the Ca2+ concentration dependence of this phenomenon
(Fig. 8). While the Hill coefficients of
1.3 are similar to those observed for Ca2+
binding to the wild-type Ca2+-ATPase in sarcoplasmic
reticulum, the K0.5 values of 0.10 and 0.05 µM for mutants D351N and D351A, respectively, are more
than 10-fold lower than those determined for sarcoplasmic reticulum Ca2+-ATPase under comparable buffer conditions by
equilibrium binding studies in the absence of nucleotide or in the
presence of nonhydrolyzable nucleotides such as AMPPCP (32,
33).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 8.
Ca2+ dependence of
TNP-8N3-ATP photolabeling of mutants D351N ( ) and D351A
( ) at pH 7.0. Photolabeling was performed as in Fig. 1 except
that the buffer contained 150 mM MOPS (pH 7.0), 5 mM EGTA, and variable calcium concentrations to yield the
free Ca2+ concentrations shown. The concentration of
[ -32P]TNP-8N3-ATP was 10 and 30 nM for mutants D351N and D351A, respectively. The data were
fitted to the Hill equation and offset (mutant D351N:
K0.5 = 0.10 µM,
nH = 1.3; mutant D351A:
K0.5 = 0.05 µM,
nH = 1.3).
|
|
For nondisruptive mutations, the interaction energies
(
GInteraction) between a side chain and
ligand can be obtained from the ratio of the dissociation constants of
wild type and mutant proteins (34). Table III shows the results of such
calculations of nucleotide-Asp351 interaction energies for
mutants D351N and D351A based on the data in Table II for wild type and
mutants in the absence of Ca2+ and some additional results
of similar studies with ADP and AMPPCP in place of ATP (see below). The
interaction energies for ATP in the presence of Ca2+ and
Mg2+ were also calculated for pH 7.0 (last line in Table
III) using the data in Table II for the mutants and the
KD(ATP) of 3 µM for the
wild type determined by rapid kinetic measurements (8). In the absence
of Ca2+, the interaction energies calculated for mutation
D351N tend to be higher than those calculated for mutation D351A. The
TNP-8N3-ATP data show no pH dependence in the absence of
Mg2+ but a strong dependence in its presence. Thus, for
both mutants there is a pronounced Mg2+-induced increase in
the interaction energy at pH 8.5, but not at pH 7.0. Thapsigargin
binding at pH 8.5 has a similar effect to lowering the pH or removing
the divalent cation. As for the ATP data, the interaction energy
calculated for mutant D351N appears to follow the general trend, being
enhanced from 1.6 to 2.6 kcal/mol by Mg2+ at pH 8.5 and by
the pH increase in the presence of Mg2+, whereas the
interaction energy calculated for mutant D351A remains close to the
lower of these two values, unaffected by Mg2+ and pH.
Ca2+, on the other hand, seems to increase the interaction
energy most strongly for mutant D351A, to as much as 4.5 kcal/mol.
The KD values determined for the binding of ADP and
AMPPCP at pH 8.5 in the presence of Mg2+ were for the wild
type 7 and 63 µM, respectively, and for mutant D351N 0.23 and 0.8 µM, respectively (data not shown, but see the derived interaction energies in Table III). Thus, the interaction energy with MgADP is lower than with MgATP but still significant. The
energy with MgAMPPCP is similar to MgATP.
 |
DISCUSSION |
Our results document the close interaction of bound nucleotides
with Asp351 and other residues in the conserved
phosphorylation loop of sarcoplasmic reticulum Ca2+-ATPase.
Elimination of the charge on Asp351, as in mutations D351N,
D351A, and D351T, enhanced the affinity for ATP and
TNP-8N3-ATP up to 156-fold in the absence of
Ca2+ and even more in the presence of Ca2+,
suggesting strong electrostatic effects between the
-phosphate and
the aspartate in the wild-type pump. In contrast, fairly conservative changes to Lys352, Thr355, Leu356,
and Thr357 impaired nucleotide binding to various extents,
suggesting that these residues either directly ligate nucleotide or
influence those that do. The removal of the positive charge of
Lys352 in mutant K352Q gave rise to a very pronounced
decrease in ATP affinity of at least 1000-fold, again revealing the
importance of electrostatic interactions at the active site. The
disruptive mutations, as well as D351N and D351A, reduced or eliminated
CrATP-induced Ca2+ occlusion.
Recently, bacterial haloacid dehalogenases have been found to be
homologous with P-type ATPases (35), and the crystal structures of the
dehalogenases provide insights into possible Ca2+-ATPase
structure. A catalytic aspartate of the dehalogenases is homologous to
Asp351 of Ca2+-ATPase and is positioned at the
end of a
-strand, which is centrally located in a
-sheet (36).
The critical aspartate leads into a spiral loop and hence to a
secondary domain, which acts like a cap over the aspartate and active
site. In the Ca2+-ATPase, the nucleotide substrate must be
positioned between the two domains, but it is not yet clear how it
would be oriented with respect to the aspartate and the phosphorylation
loop. Crude modeling suggests that Lys352 may be involved
in direct interaction with the nucleotide, and the disruptive influence
of even K352R on ATP binding is compatible with a role for this lysine
in direct ligation. Leu356 and Thr357 do not
appear to be able to interact directly with the nucleotide but rather
appear to brace Asp351 and Lys352 and lead into
the hinge segment between the main phosphorylation domain and the
secondary cap domain. Mutation L356T was severely disruptive and seemed
to prevent photolabeling of Lys492 (expected to be part of
the cap domain and some distance away from Leu356). If this
is occurring by shifting the position of Lys492, it would
indicate interdomain communication between critical regions of the
protein and point to Leu356 being in a pivotal position.
Alternatively, the nucleotide affinity may have been reduced as a
result of displacement of Asp351 and Lys352.
Thr355 appears to play a minor role in ATP binding, and
perhaps the ATP molecule is oriented away from this residue, and its
apparently crucial role in phosphorylation (19) may be catalytic, a
conclusion supported by the strong conservation of this residue in both
P-type pumps and dehalogenases (35).
Mutations D351N, D351A, and D351T generally caused large increases in
affinity for TNP-8N3-ATP and ATP, suggesting the existence of a strong electrostatic repulsion between the aspartate and the
-phosphoryl group of ATP, which obscures a high intrinsic binding
energy. These results are in line with the findings of Pedersen
et al. (6) on renal Na+,K+-ATPase,
which demonstrated increases of up to 39-fold in the absence of
Mg2+ following mutation of the equivalent aspartate
(Asp369) to alanine. We obtained increases of 17- and
66-fold for mutations D351A and D351N, respectively, under comparable
conditions at pH 7.0 in EDTA. In many of the conditions tested, we
found larger affinity increases for the asparagine substitution than
for the alanine substitution, in contrast to what was found for the
Na+,K+-ATPase, where the alanine substitution
appears to be the more effective. It may furthermore be noted that the
Na+,K+-ATPase D369N mutant showed no
significant change (or possibly a slight decrease) in affinity for ADP
relative to the wild type, whereas a 30-fold increase in affinity for
MgADP was demonstrated for the corresponding Ca2+-ATPase
mutant. This difference may possibly be ascribed to the presence of
Mg2+ (see below).
The results obtained with mutant D351N in the absence of
Ca2+ reveal that the increase in nucleotide affinity
induced by the mutation (nucleotide-Asp351 interaction
energies, 
GInteraction, Table III) is
largest at alkaline pH in the presence of Mg2+.
Mg2+ increases the interaction energy (or electrostatic
repulsion) between the
-phosphoryl group and Asp351 at
pH 8.5 but has little effect at pH 7.0. Since the E1 form of the pump
is expected to prevail at pH 8.5, whereas the E2H and E2H3
forms accumulate at pH 7.0 when Ca2+ is absent (7), our
data suggest that the Mg2+ effect depends on the enzyme
being in the E1 form.
ATP has two negative charges on the
-phosphoryl group at pH 8.5 and
is partially protonated at pH 7.0 (pKa = 6.63), whereas MgATP can be expected to have a single negative charge at both
pH values (pKa = 4.72) (37). Mg2+ might
have been expected to decrease the electrostatic interaction at both pH
values. Also, Mg2+ is expected to polarize the P-O bond,
withdrawing electronegativity from the phosphorus atom, which should
further reduce the repulsion. But these ameliorating effects of
Mg2+ appear to be counteracted by an increased binding
interaction and a rise in repulsion as reflected in the change in
interaction energy from 1.6 kcal/mol to 2.6 kcal/mol, resulting from
Mg2+ binding at pH 8.5 in the case of mutant D351N. This is
probably the result of Mg2+ assisting a close approach of
the
-phosphoryl group and the carboxylate anion in the E1 state.
In the presence of Mg2+, the decrease in
nucleotide-Asp351 interaction energy observed for the D351N
mutant when the pH is reduced from 8.5 to 7.0 is roughly equivalent to
the decrease seen upon thapsigargin binding or replacement of MgATP
with MgADP. This is consistent with the hypothesis that, in the first
two instances, the
-phosphoryl group is withdrawn 3-4 Å from
Asp351, or approximately the length of a phosphate group.
Since E2 states are expected to prevail both at the lower pH and in the
presence of thapsigargin, the displacement of nucleotide from the
phosphorylation loop under these conditions is compatible with other
findings that ATP and Pi can bind simultaneously at the
active site in E2 states (10-14).
The ATP-Asp351 interaction energy calculated for mutant
D351A at alkaline pH in the presence of Mg2+ is similar to
the interaction energy calculated for D351N at pH 7.0 in the presence
of Mg2+. For mutant D351A, there is furthermore little
effect of reducing the Mg2+ concentration or pH. The reason
could be that mutation D351A to some extent counteracts the influence
of alkaline pH on the E1-E2 conformational equilibrium in the absence
of Ca2+. This would be equivalent to the displacement of
the equilibrium in favor of E2 reported for the D369A mutation in the
Na+,K+-ATPase (6).
A central observation in the present study is that Ca2+
binding to the transport sites causes a substantial increase in the intrinsic nucleotide binding energy of either of the mutants D351N and
D351A at pH 7.0 and of D351A at pH 8.5. The same results were obtained
both with the photolabeling assay and a direct filtration assay. In the
case of mutant D351A at pH 7.0, the affinity for MgATP is increased
300-fold upon Ca2+ binding. The affinity of the wild-type
Ca2+-ATPase for MgATP in the presence of Ca2+
cannot be measured directly in equilibrium binding experiments due to
the activation of phosphoryl transfer by Ca2+, but it has
been estimated from rapid kinetic determinations of association and
dissociation rate constants to be very similar to the affinity in the
absence of Ca2+ at pH 7.0 (8). The very large increase in
MgATP affinity induced by Ca2+ binding in mutant D351A may
possibly be ascribed to a close resemblance of the E1Ca2
complex of mutant D351A with MgATP to the transition state for
phosphoryl transfer (a "pseudotransition state"), the only
difference from the transition state in the wild type being the absence
of strong electrostatic effects corresponding to an interaction energy
of as much as 4.5 kcal/mol (Table III). The reason why the
corresponding complex of mutant D351N is less tight may be that the
amino hydrogens of the asparagine impose steric hindrance to the
closest possible approach of the
-phosphoryl group of ATP, whereas
the shorter alanine side chain with attendant void can be accommodated.
This would be especially critical in an associative mechanism of
phosphoryl transfer (where there is substantial bond formation between
the oxyanion of the carboxylate and the phosphorus atom while the bond
between the
-phosphorus and the bridging oxygen is being broken)
compared with a dissociative mechanism (where a distinct metaphosphate
intermediate is generated) (see Scheme
2).
In light of the Ca2+ effects on nucleotide affinities
described here, it is noteworthy that the ATP affinity of the
Na+,K+-ATPase mutant D369A appeared to be
unaffected by the presence of Na+ (6), although this cation
plays a role as activator of the phosphorylation reaction in
Na+,K+-ATPase equivalent to that of
Ca2+ in the Ca2+-ATPase. A likely explanation
is that the studies on Na+,K+-ATPase mutants
were conducted in the absence of Mg2+, which is also
required at the catalytic site for transition state formation and,
thus, for attainment of the extremely high nucleotide affinity.
The Ca2+ activation of phosphorylation in the wild-type
Ca2+-ATPase and of nucleotide binding with very high
affinity in the D351A and D351N mutants implies that signals
originating in the Ca2+ transport sites in the membrane are
conveyed by protein conformational changes over long distance to the
catalytic site in the cytoplasmic protein domain. Signals originating
at the catalytic site are likewise transmitted in the reverse direction
from the cytoplasmic portion down the stalk to the Ca2+
sites (5, 38). Hence, in the wild-type enzyme the phosphorylation of
Asp351 (or perhaps already the formation of the transition
state) leads to occlusion of Ca2+. The occluded
Ca2+ is released from the phosphoenzyme only following
conformational changes that open the binding pocket toward the luminal
side of the membrane (38, 39). An intriguing question was, therefore, whether mutations D351N and D351A elicited events at the catalytic site
that were transmitted to the membrane domain, affecting the Ca2+ binding properties of the transport sites. We tested
the affinity for Ca2+ in mutants D351N and D351A by making
use of the Ca2+-induced increase in affinity for
TNP-8N3-ATP at pH 7.0. The results show that the apparent
Ca2+ affinities of the mutants were significantly higher
than the literature values for the wild-type Ca2+-ATPase in
sarcoplasmic reticulum determined under comparable conditions in the
presence or absence of nonhydrolyzable nucleotide (32, 33) and highest
in the case of mutation D351A. In our assay for Ca2+
binding (Fig. 8), the concentration of TNP nucleotide present was by
necessity only partially saturating for the most part, and therefore
the KD values for Ca2+ binding to mutant
proteins with bound nucleotide should be even lower than the 0.1 and
0.05 µM indicated by the data in the figure. Also, the
"principle of linked functions" (40) resulting from basic
thermodynamics predicts that when Ca2+ binding increases
the affinity for nucleotide, then nucleotide binding should
correspondingly increase the affinity for Ca2+. Hence, the
results support the hypothesis that in the pseudotransition state
induced by the mutations in the presence of nucleotide, Ca2+ is bound with increased affinity relative to the
normal E1 state of the wild-type enzyme.
Incubation of the Ca2+-ATPase with CrATP as substitute for
ATP leads to gradual formation of a very slowly dissociating complex with the active site without phosphorylating Asp351, and
simultaneously Ca2+ bound at the transport sites becomes
stably occluded (24-27). The complex with CrATP may mimic to some
extent a pretransition state, the transition state, or the
phosphorylated state (38). Our findings with the D351N and D351A
mutants seem to suggest that Asp351 is critical for CrATP
complexation and, thus, for the accompanying Ca2+
occlusion. The mechanism behind the development of the slowly dissociating complex over time is unknown, but it might involve replacement of the Cr3+-coordinated waters with protein
ligands, and if this is the case then the carboxylate of
Asp351 appears to be one of these. Caution is needed in
interpreting these results, because even traces of ATP present as
contaminant in the CrATP preparation might be able to compete
efficiently with CrATP for binding to the mutants due to their very
high ATP affinity. However, we have not been able to detect any
significant level of ATP contamination in the purified CrATP
preparation that was used.
In conclusion, the present results seem to support the following ideas
concerning the mechanism of catalysis and energy transduction in the
initial part of the Ca2+-ATPase reaction cycle. At pH 7.0 and before the binding of Ca2+, MgATP binds fairly tightly
such that the nucleotide and Asp351 may be poised
electrostatically repelling each other to the extent of approximately
1.6 kcal/mol. Ca2+ binding at the transport sites causes a
significant increase in the favorable nucleotide-active site
interactions, to the extent of approximately 2.9 (4.5
1.6)
kcal/mol, which in the wild type may be used to balance an increase in
the electrostatic repulsion between the
-phosphate and
Asp351, thereby facilitating the phosphoryl transfer. The
Ca2+-induced conformational change could involve the
repositioning of a positively charged residue, such as a lysine, in
proximity to the
-phosphate and Asp351 to create a salt
linkage with the phosphate. This mechanism finds support in the
Ca2+-dependent cross-linking of a lysyl residue
to Asp351 (41) and the involvement of a lysyl residue in
the catalytic mechanism of haloacid dehalogenases (35). In the
Ca2+-ATPase, the events at the catalytic site elicit
further conformational changes in the Ca2+ binding domain
that increase the Ca2+ affinity and bring about occlusion
of the Ca2+ sites.
 |
ACKNOWLEDGEMENTS |
We thank Karin Kracht and Lene Jacobsen for
expert technical assistance and Dr. R. J. Kaufman (Genetics
Institute, Boston) for the gift of the expression vector pMT2.
 |
FOOTNOTES |
*
This study was funded in part by grants from by the
Foundation for Research Development of South Africa (to D. B. M. and
D. G. W.); the Danish Medical Research Council, the NOVO Nordisk Foundation, Denmark, and the Research Foundation of Aarhus University (to B. V. and J. P. A.); and the Medical Research Council of Canada (to D. H. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence may be addressed: Dept. of Chemical
Pathology, University of Cape Town Medical School, Observatory, 7925, Cape Town, South Africa. Fax: 27-21-4488150; E-mail: davidmci@ chempath.uct.ac.za.
§
To whom correspondence may be addressed: Dept. of Physiology,
University of Aarhus, Ole Worms All 233 160, Universitetsparken, DK8000 Aarhus, C, Denmark. Fax: 45-86-12-90-65; E-mail: jpa@fi. au.dk.
 |
ABBREVIATIONS |
The abbreviations used are:
TNP-8N3-ATP, 2',3'-O-(2,4,6-trinitrophenyl)-8-azido-adenosine triphosphate;
TNP, trinitrophenyl;
AMPPCP, adenylyl
,
-methylene triphosphate;
CrATP,
,
-bidentate chromium(III) complex of ATP;
E1 and E2, major
conformational states of Ca2+-ATPase;
MOPS, 3-(N-morpholino)propanesulfonic acid;
HEPPS, N-2-hydroxyethylpiperazine-N'-3-propanesulfonic
acid;
HPLC, high pressure liquid chromatography;
TES, 2-{[2-hydroxy-1,1-bis(hy-droxymethyl)ethyl]amino}ethanesulfonic
acid;
TMAH, tetramethyl ammonium hydroxide.
 |
REFERENCES |
| 1.
|
Hasselbach, W.,
and Makinose, M.
(1961)
Biochem. Z.
333,
518-528[Medline]
[Order article via Infotrieve]
|
| 2.
|
MacLennan, D. H.,
Brandl, C. J.,
Korzak, B.,
and Green, N. M.
(1985)
Nature
316,
696-700[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Levy, D.,
Seigneuret, M.,
Bluzat, A.,
and Rigaud, J-L.
(1990)
J. Biol. Chem.
265,
19524-19534[Abstract/Free Full Text]
|
| 4.
|
Degani, C.,
and Boyer, P. D.
(1973)
J. Biol. Chem.
248,
8222-8226[Abstract/Free Full Text]
|
| 5.
|
MacLennan, D. H.,
Rice, W. J.,
and Green, N. M.
(1997)
J. Biol. Chem.
272,
28815-28818[Free Full Text]
|
| 6.
|
Pedersen, P. A.,
Rasmussen, J. H.,
and Jorgensen, P. L.
(1996)
Biochemistry
35,
16085-16093[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Forge, V.,
Mintz, E.,
and Guillain, F.
(1993)
J. Biol. Chem.
268,
10953-10960[Abstract/Free Full Text]
|
| 8.
|
Lacapère, J-J.,
and Guillain, F.
(1993)
Eur. J. Biochem.
211,
117-126[Medline]
[Order article via Infotrieve]
|
| 9.
|
Lacapère, J-J.,
Bennett, N.,
Dupont, Y.,
and Guillain, F.
(1990)
J. Biol. Chem.
265,
348-353[Abstract/Free Full Text]
|
| 10.
|
Pickart, C. M.,
and Jencks, W. P.
(1984)
J. Biol. Chem.
259,
1629-1643[Abstract/Free Full Text]
|
| 11.
|
Champeil, P.,
Riollet, S.,
Orlowski, S.,
Guillain, F.,
Seebregts, C. J.,
and McIntosh, D. B.
(1988)
J. Biol. Chem.
263,
12288-12294[Abstract/Free Full Text]
|
| 12.
|
McIntosh, D. B.,
and Boyer, P. D.
(1983)
Biohemistry
22,
2867-2875
[CrossRef][Medline]
[Order article via Infotrieve] |
| 13.
|
Andersen, J. P.,
and Moller, J. V.
(1985)
Biochim. Biophys. Acta
815,
9-15[Medline]
[Order article via Infotrieve]
|
| 14.
|
McIntosh, D. B.,
Woolley, D. G.,
and Berman, M. C.
(1992)
J. Biol. Chem.
267,
5301-5309[Abstract/Free Full Text]
|
| 15.
|
McIntosh, D. B.,
and Woolley, D. G.
(1994)
J. Biol. Chem.
269,
21587-21595[Abstract/Free Full Text]
|
| 16.
|
McIntosh, D. B.,
Woolley, D. G.,
Vilsen, B.,
and Andersen, J. P.
(1996)
J. Biol. Chem.
271,
25778-25789[Abstract/Free Full Text]
|
| 17.
|
Green, N. M.
(1989)
Biochem. Soc. Trans.
17,
970-972
|
| 18.
|
Maruyama, K.,
and MacLennan, D. H.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
3314-3318[Abstract/Free Full Text]
|
| 19.
|
Maruyama, K.,
Clarke, D. M.,
Fujii, J.,
Inesi, G.,
Loo, T. W.,
and MacLennan, D. H.
(1989)
J. Biol. Chem.
264,
13038-13042[Abstract/Free Full Text]
|
| 20.
|
Kaufman, R. J.,
Davies, M. V.,
Pathak, V. K.,
and Hershey, J. W. B.
(1989)
Mol. Cell. Biol.
9,
946-958[Abstract/Free Full Text]
|
| 21.
|
Vilsen, B.,
Andersen, J. P.,
and MacLennan, D. H.
(1991)
J. Biol. Chem.
266,
16157-16164[Abstract/Free Full Text]
|
| 22.
|
Seebregts, C. J.,
and McIntosh, D. B.
(1989)
J. Biol. Chem.
264,
2043-2052[Abstract/Free Full Text]
|
| 23.
|
Fabiato, A.,
and Fabiato, F.
(1979)
J. Physiol.
75,
463-505
|
| 24.
|
Vilsen, B.,
and Andersen, J. P.
(1992)
J. Biol. Chem.
267,
25739-25743[Abstract/Free Full Text]
|
| 25.
|
Serpersu, E. H.,
Kirch, U.,
and Schoner, W.
(1982)
Eur. J. Biochem.
122,
347-354[Medline]
[Order article via Infotrieve]
|
| 26.
|
Vilsen, B.,
and Andersen, J. P.
(1986)
Bochim. Biophys. Acta
855,
429-431
[Medline]
[Order article via Infotrieve] |
| 27.
|
Vilsen, B.,
and Andersen, J. P.
(1992)
J. Biol. Chem.
267,
3539-3550[Abstract/Free Full Text]
|
| 28.
|
Sagara, Y.,
Wade, J. B.,
and Inesi, G.
(1991)
J. Biol. Chem.
267,
1286-1292[Abstract/Free Full Text]
|
| 29.
|
Meissner, G.
(1973)
Biochim. Biophys. Acta
298,
906-926[Medline]
[Order article via Infotrieve]
|
| 30.
|
Reinstein, J.,
and Jencks, |